"The Regional Cancer Center at Indian Path Community Hospital offers radiation, medical oncology treatment programs and more. A team of experienced nurses, therapists and other healthcare professionals back our oncologists during your treatment."

During the past decade, Regional Cancer Center at Indian Path Community Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 10 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Cancer Center at Indian Path Community Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 6 trials, followed by "National Cancer Institute (NCI)" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Daiichi Sankyo, Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Cancer Center at Indian Path Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Regional Cancer Center at Indian Path Community Hospital" are "Breast Adenocarcinoma" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials), "Fatigue" (2 trials), "HER2/Neu Negative" (2 trials) and "Stage IIA Breast Cancer" (2 trials). Many other conditions were trialed in "Regional Cancer Center at Indian Path Community Hospital" in a lesser frequency.

Most popular intervention types in "Regional Cancer Center at Indian Path Community Hospital" are "Drug" (15 trials), "Other" (14 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (5 trials), "Laboratory Biomarker Analysis" (4 trials), "Gemcitabine Hydrochloride" (2 trials), "Paclitaxel" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Regional Cancer Center at Indian Path Community Hospital" are 17 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Regional Cancer Center at Indian Path Community Hospital". undefined are not yet recruiting, 2 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Regional Cancer Center at Indian Path Community Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Cancer Center at Indian Path Community Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".